FSD Pharma Congratulates Cannara Biotech for Its Listing and Commencement of Trading on the CSE

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) would like to congratulate Cannara Biotech Inc. (“Cannara”) for its listing approval and commencement of trading on the Canadian Securities Exchange (“CSE”) today under the stock symbol “LOVE”. FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares (“Common Shares”) of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer. read more

FSD Pharma Announces Holdings in Cannara Biotech Inc.

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares (“Common Shares“) of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer. read more

Cartier Continues to Widen Zones 5 below Chimo Mine with 14.6 g/t Au over 3.0 m within 5.8 g/t Au over 10.0 m

Cartier Resources

Cartier Resources Inc. (TSX-V: ECR) (“Cartier”) reports additional drill hole intersections grading 14.6 g/t Au over 3.0 m including 36.8 g/t Au over 1.0 m, 450 m below the Chimo Mine (FIGURE). These higher-grade sections are included within a section grading 5.8 g/t Au over 10.0 m included within an interval of 44.0 m grading 2.2 g/t Au. The Chimo Mine project is situated 45 Km east of Val-d’Or within the prolific Val-d’Or Mining Camp. Results continue to confirm the robustness of the gold system below the former mine. read more